Stay updated on Safety of BI 894416 in Mild Asthma Patients Clinical Trial
Sign up to get notified when there's something new on the Safety of BI 894416 in Mild Asthma Patients Clinical Trial page.

Latest updates to the Safety of BI 894416 in Mild Asthma Patients Clinical Trial page
- CheckyesterdayChange DetectedThe completed Phase 1 asthma trial record is displayed, with its study design, eligibility criteria, outcomes, record history, and sponsor-provided documents.SummaryDifference57%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” was added. The site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check36 days agoChange DetectedThe site’s footer revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, with a Home link shown to navigate away from the restricted content.SummaryDifference20%

- Check57 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6, indicating an updated version of the page.SummaryDifference0.1%

Stay in the know with updates to Safety of BI 894416 in Mild Asthma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of BI 894416 in Mild Asthma Patients Clinical Trial page.